Investment Cases
R

Research Desk

@reserach_desk · 4 Published Cases
Track Record
Avg Return
-4.3%
4 priced cases
Working
50%
Cases in the money
Targets Hit
0
0 stops hit
Hit Rate
—
Targets vs stops, closed cases
By conviction3/5: -1.5% (3)4/5: -12.5% (1)

Returns are on each case's own side since publication; closed cases are frozen at the close. Every published case counts, including the ones that didn't work. Methodology

$ORCLSHORT

Oracle has transformed itself from a cash-generative software franchise into a leveraged AI infrastructure contractor, taking on junk-adjacent debt to build data centres for a single customer whose own financial stability is uncertain. The stock, already down roughly 56% from its 52-week high, still prices in flawless execution of a capex programme that is burning cash faster than management guided and that three rating agencies now view as structurally risky.

Published Oct 6, 2026
$NKELONG

Nike's stock has been reset to multi-year lows on a guidance cut that the market is treating as a permanent impairment, but the underlying brand franchise -- still the world's largest athletic footwear company by market share -- retains structural advantages that a trough valuation does not reflect. The long case rests on brand durability surviving a cyclical reset, with margin recovery and cost savings providing the financial bridge.

Published Oct 6, 2026
$FCELLONG

FuelCell Energy has pivoted credibly into AI data center power, securing its first committed equipment order (up to 380 MW with Fit Energy) and a 75 MW capacity reservation in Texas, while the stock sits roughly 53% below its 52-week high after a Q3 earnings miss. The market is discounting near-term margin pain and missing the scale of the commercial pipeline, which reached approximately 10 GW by end of Q3 fiscal 2026.

Published Oct 6, 2026
$STMLONG

STMicroelectronics is emerging from a severe two-year down-cycle with accelerating revenue momentum, a data center revenue ramp that management has guided above $1 billion in 2026 and above $2 billion in 2027, and a manufacturing restructuring program that should drive 400+ basis points of gross margin improvement by 2027-2028. The stock has recovered sharply from its 52-week low but still trades well below consensus price targets and its prior-cycle peak, leaving meaningful upside if the earnings recovery tracks guidance.

Published Oct 6, 2026

Personal investment cases published by @reserach_desk. For information only; not investment advice or a recommendation to buy or sell any security. Price changes are measured from the price at publication.